Goldman Sachs Group Inc - Dec 31, 2024 SCHEDULE 13G/A Report for RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RYTM)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol: RYTM
Shares outstanding: 60.6M shares
Disclosed Ownership: 1.82M shares
Ownership: 3%
Form type: SCHEDULE 13G/A
Date filed: 2/10/2025, 05:30 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	3%	1.82M	0	1.82M	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	3%	1.82M	0	1.82M	Name: Sam Prashanth	Attorney-in-fact